In the first comprehensive, cell-by-cell analysis of brain tissue from individuals with Tourette syndrome, researchers have ...

In the first comprehensive, cell-by-cell analysis of brain tissue from individuals with Tourette syndrome, researchers have ...

Using in-vitro models of a specific type of brain cell, scientists have demonstrated that neurons can transform from one type ...

The round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial - The ...

- The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, Soleus Capital, Viking Global Investors, and Cormorant Asset ...

(MENAFN- GlobeNewsWire - Nasdaq) - The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, Soleus Capital, Viking ...

Neurona is developing allogeneic, off-the-shelf, regenerative neural cell therapy product candidates with the potential to provide long-term targeted repair of the nervous system following a ...

- The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, Soleus Capital, Viking Global Investors, and Cormorant Asset ...